<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01988298</url>
  </required_header>
  <id_info>
    <org_study_id>Complejoh 02</org_study_id>
    <nct_id>NCT01988298</nct_id>
  </id_info>
  <brief_title>Nonsteroidal Antiinflammatory Drugs in Women With Postpartum Pre-eclampsia</brief_title>
  <official_title>Ibuprofen Versus Acetaminophen in Women With Severe Pre-eclampsia After Vaginal Delivery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Complejo Hospitalario Dr. Arnulfo Arias Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Complejo Hospitalario Dr. Arnulfo Arias Madrid</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypertensive disorders of pregnancy are a major cause of maternal mortality and morbidity,
      especially in developing countries. Postpartum hypertension can be related to persistence of
      gestational hypertension, preeclampsia, or preexisting chronic hypertension, or it could
      develop de novo secondary to other causes. The available data in the medical literature have
      primarily focused on antenatal and peripartum management. There are few data regarding the
      evaluation in women who are diagnosis with postpartum hypertension. Some medications that
      cause vasoconstriction are often used for pain relief, in women having perineal lacerations,
      episiotomy, or cesarean delivery. Such women usually require large doses of nonsteroidal
      antiinflammatory drugs that are associated with vasoconstriction and sodium and water
      retention, this drugs can result in severe hypertension.

      The purpose of this study is to evaluate maternal postpartum hypertension in women with
      severe preeclampsia treated with nonsteroidal antiinflammatory drugs or acetaminophen.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Our objective is evaluate Ibuprofen or acetaminophen used for pain during the postpartum
      period in women with severe pre-eclampsia. We include only women with vaginal delivery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>level of postpartum hypertension</measure>
    <time_frame>levels of hypertension up to 4 days post paertum</time_frame>
    <description>hypertension during the postpartum using acetaminophen or nonsteroidal antiinflammatory</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>complications</measure>
    <time_frame>complications during the postpartum period (4 days)</time_frame>
    <description>Renal failure, symptoms, bleeding</description>
  </secondary_outcome>
  <other_outcome>
    <measure>convulsions</measure>
    <time_frame>maternal complicactions for 4 days postpartum</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">114</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Ibuprofen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental: Ibuprofen 400 mg each 8 hours for 2-3 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Acetaminophen 1 g oral each 6 hours, 2-3 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>Ibuprofen 400 mg each 8 hours</description>
    <arm_group_label>Ibuprofen</arm_group_label>
    <other_name>Ibuprofen in pre-eclampsia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>Control group</description>
    <arm_group_label>Acetaminophen</arm_group_label>
    <other_name>Acetaminophen in pre-eclampsia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Vaginal delivery severe pre-eclampsia severe gestational hypertension aggregate
        pre-eclampsia

        Exclusion Criteria:

        sensitivities to ibuprofen cesarean delivery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paulino Vigil-De Gracia, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Complejo Hospitalario Caja de Seguro social</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Paulino Vigil-De Gracia</name>
      <address>
        <city>Panam√°</city>
        <country>Panama</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Panama</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2013</study_first_submitted>
  <study_first_submitted_qc>November 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2013</study_first_posted>
  <last_update_submitted>July 27, 2015</last_update_submitted>
  <last_update_submitted_qc>July 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Complejo Hospitalario Dr. Arnulfo Arias Madrid</investigator_affiliation>
    <investigator_full_name>Paulino Vigil-De Gracia</investigator_full_name>
    <investigator_title>Gynecology and obstetric, investigator and teaching proffesor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eclampsia</mesh_term>
    <mesh_term>Pre-Eclampsia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

